ResearcherNankai UniversityNo recent work listed
Meiyan Shi
Known by name at one institution; no external author ID yet. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2015: 1 paper · 2016: 1 paper
Papers 2
- Hypoxia regulates ABCG2 activity through the activivation of ERK1/2/HIF-1α and contributes to chemoresistance in pancreatic cancer cells. Co-author DOI 10.1080/15384047.2016.1139228↗
- Tenascin-C induces resistance to apoptosis in pancreatic cancer cell through activation of ERK/NF-κB pathway. Co-author DOI 10.1007/s10495-015-1106-4↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiaohong Shen · 2 shared papers, 2015–2016 · strength 0.13
- Paper Hypoxia regulates ABCG2 activity through the activivation of ERK1/2/HIF-1α and contributes to chemoresistance in pancre… DOI 10.1080/15384047.2016.1139228↗
- Paper Tenascin-C induces resistance to apoptosis in pancreatic cancer cell through activation of ERK/NF-κB pathway. DOI 10.1007/s10495-015-1106-4↗
- Xiaodan He · 2 shared papers, 2015–2016 · strength 0.13
- Paper Hypoxia regulates ABCG2 activity through the activivation of ERK1/2/HIF-1α and contributes to chemoresistance in pancre… DOI 10.1080/15384047.2016.1139228↗
- Paper Tenascin-C induces resistance to apoptosis in pancreatic cancer cell through activation of ERK/NF-κB pathway. DOI 10.1007/s10495-015-1106-4↗
- Beibei Xin · 1 shared paper, 2016 · strength 0.07
- Juan Wang · 1 shared paper, 2015 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.